Fundamental mechanisms of apoptosis and phospholipid asymmetry
Project Number3R35GM118188-04S2
Former Number5R35GM118188-04
Contact PI/Project LeaderXUE, DING
Awardee OrganizationUNIVERSITY OF COLORADO
Description
Abstract Text
Project summary
Programmed cell death, phospholipid asymmetry, and paternal mitochondrial elimination are three vitally
important, distinct, and interconnected biological processes essential for normal cell functions and animal
development. Defects in these processes can cause various pathological conditions and human disease,
including neurodegenerative disease, autoimmune disorders, various inherited human mitochondrial disease,
and cancer. In this proposed work, we will carry out molecular genetic, reverse genetic, biochemical, cell
biological, biophysical, and functional genomic analyses to decipher basic mechanisms of apoptosis,
phospholipid asymmetry, and paternal mitochondrial elimination during animal development. For the study of
apoptosis, we hope to understand the regulatory mechanisms and signaling pathways that control the release
of mitochondrial apoptogenic factors during apoptosis and identify new targets and downstream pathways of
the cell death protease that execute highly organized cell disassembly and rapid removal of the dying cells. For
the study of phospholipid asymmetry, we plan to identify the molecular components and regulatory
machineries that generate, maintain, and alter phospholipid asymmetry, decipher the functions and roles of
specific phospholipids to a cell, and reveal the physiological and pathological consequences of altered
phospholipid asymmetry to the cell and the animal. For the study of paternal mitochondrial elimination, we will
investigate how and why paternal mitochondria are selectively recognized and targeted for elimination, the
paternal and maternal factors and machineries required of this uniparental inheritance process, and the
physiological significance of paternal mitochondrial elimination to embryo development and organismal fitness.
These studies should reveal novel mechanisms, pathways, and genes that control these three fundamental
biological processes, and ultimately, provide new targets, ideas, and strategies to facilitate treatment of
numerous human diseases caused by abnormalities in these three important processes.
Public Health Relevance Statement
Project Narrative
Apoptosis, lipid asymmetry in biological membranes, and paternal mitochondrial elimination in embryo
development are three vitally important, distinct, and interconnected biological processes essential for normal
cell functions and organismal development. Defects in these three processes can cause multiple human
diseases, such as neurodegenerative disease, autoimmune disorders, inherited human mitochondrial disease,
and cancer. This proposal seeks to understand the mechanisms that regulate and execute these three
fundamental biological events and identify new genes and pathways important for these three processes,
leading to identification of new therapeutic targets or ideas to treat human disease such as Alzheimer's
disease, autoimmune disorders, and cancer that are caused by abnormalities in these three important
processes.
No Sub Projects information available for 3R35GM118188-04S2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R35GM118188-04S2
Patents
No Patents information available for 3R35GM118188-04S2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R35GM118188-04S2
Clinical Studies
No Clinical Studies information available for 3R35GM118188-04S2
News and More
Related News Releases
No news release information available for 3R35GM118188-04S2
History
No Historical information available for 3R35GM118188-04S2
Similar Projects
No Similar Projects information available for 3R35GM118188-04S2